Cefteram

• CAT Number: R048882
• CAS Number: 82547-58-8
• Molecular Formula: C16H17N9O5S2
• Molecular Weight: 479.49
• Purity: ≥95%
• Synonyms: (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(5-methyltetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• InChI: InChI=1S/C16H17N9O5S2/c1-6-20-23-24(21-6)3-7-4-31-14-10(13(27)25(14)11(7)15(28)29)19-12(26)9(22-30-2)8-5-32-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b22-9-/t10-,14-/m1/s1
• InChIKey: XSPUSVIQHBDITA-RKYNPMAHSA-N
• SMILES: CC1=NN(N=N1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O

Cefteram(CAT: R048882) is a third-generation cephalosporin antibiotic, widely used in bacterial infection research. It exhibits broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacteria, inhibiting bacterial cell wall synthesis by targeting penicillin-binding proteins (PBPs). Cefteram is effective against respiratory tract infections, urinary tract infections, and skin infections, making it a valuable tool for antimicrobial resistance studies and drug development. Its oral bioavailability enhances its application in pharmacokinetics and drug efficacy research. Suitable for biochemical, microbiological, and preclinical studies, Cefteram is for research use only; not for human or clinical applications.